- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Evoq Remedies released its Annual Report and called its Annual General Meeting. While revenue rose to ₹14.17 Cr, net profit fell to ₹0.09 Cr. The company increased its authorized capital to ₹42 Cr. Shareholders will vote on substantial related party transactions, each up to ₹50 Cr over five years. Auditors flagged serious issues: significant unpaid taxes and old related party debtors, plus ₹25.06 Cr in related party loans (some from preferential funds) with compliance gaps. SEBI is investigating financials and fund use. Auditors expressed inability to confirm a true and fair view, citing audit trail and internal audit failures. #EvoqRemedies #AGM #Financials #RPT #AuditAlert